BioSpace News Archive

Could These Drugs Become Blockbusters in the Next 4 Years?

Clarivate Analytics has pegged 11 drugs set to enter the market this year as potential blockbusters by 2024, meaning each will achieve annual sales of more than $1 billion.

February 18, 2020

·

2 min read

·

Alex Keown

Genetown

Lytica Snags CARB-X Funding for Antibacterial Peptide Research

Lytica Therapeutics secured $5.3 million in funding to support the development of antibacterial peptides with broad activity against multidrug-resistant bacteria.

February 18, 2020

·

2 min read

·

Alex Keown

Drug Development

CicloMed Presents New Oncology Data from Phase I Trial with Fosciclopirox at 2020 ASCO Genitourinary Cancers Symposium

First-time results from recently completed fosciclopirox Phase I safety, dose tolerance, pharmacokinetics and pharmacodynamics trial in advanced solid-tumor patients

February 18, 2020

·

3 min read

New gene mutation associated with Fabry cardiomyopathy

The A143T variant of the GLA gene is associated with an increased risk of Fabry cardiomyopathy, according to a new study.

February 18, 2020

·

4 min read

Business

Silence Therapeutics Launches Scientific Advisory Board

World-leading scientists and clinicians steer Silence’s ground-breaking siRNA research programme into disease areas with high unmet medical need

February 18, 2020

·

4 min read

Business

Swiss-based Deep Cube Announces Collaboration With University Hospital Of Geneva To Develop Highly Efficient Artificial Intelligence-based Algorithms For Accurately Diagnosing Early Stage Alzheimer’s Disease

Founded in 2018 and based in Lausanne Epalinges at BIOPOLE in Switzerland, Deep Cube SA specializes in developing innovative artificial intelligence technology based on Deep Learning.

February 18, 2020

·

1 min read

Drug Development

Bellerophon Announces Positive Topline Results from INOpulse Study

The trial evaluated INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF).

February 18, 2020

·

2 min read

·

Mark Terry

BioMidwest

Celerion Expands Clinical Research to Nebraska Innovation Campus

Nebraska Innovation Campus has announced a new partner. Dan Duncan, NIC’s executive director, said Celerion will move into this space on the campus in February of 2020.

February 18, 2020

·

3 min read

Deals

4basebio AG announces results of the public share buyback offer and final purchase price for the share buy back

David Roth, Chief Financial Officer of 4basebio AG, comments: “4basebio can now successfully acquire the desired number of shares in full.

February 18, 2020

·

3 min read

Pharm Country

Castor provides free access to data capture platform to support non-profit COVID19 research projects

Castor, a health-tech company that enables medical researchers to capture standardized data to support data driven medical decision making, announced that it will provide free access to its data capture system to all non-profit COVID-19 research projects.

February 18, 2020

·

3 min read